Analystreport

Alder Biopharmaceuticals Inc (NASDAQ: ALDR) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806